European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: Practical guidance for use in patients at very high cardiovascular risk

  1. Landmesser, U.
  2. Chapman, M.J.
  3. Farnier, M.
  4. Gencer, B.
  5. Gielen, S.
  6. Hovingh, G.K.
  7. Lüscher, T.F.
  8. Sinning, D.
  9. Tokgözoǧlu, L.
  10. Wiklund, O.
  11. Zamorano, J.L.
  12. Pinto, F.J.
  13. Catapano, A.L.
Revista:
European Heart Journal

ISSN: 1522-9645,  0195-668X

Any de publicació: 2017

Volum: 38

Número: 29

Pàgines: 2245-2255

Tipus: Article

DOI: 10.1093/EURHEARTJ/EHW480 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus